137 Participants Needed

Signia Circular Stapler for Rectal Disease

(SECURE Trial)

Recruiting at 3 trial locations
SM
YY
Overseen ByYeshareg Yismaw
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to evaluate the safety and effectiveness of a new surgical tool, the Signia circular stapler, in patients undergoing specific types of bowel surgery. It focuses on procedures involving the left side of the colon or the rectum, where a section is removed and the remaining ends are joined. Prospective participants should plan to have this type of elective surgery and agree to use the Signia tool during the operation. As an unphased trial, this study offers patients the chance to contribute to innovative surgical advancements.

Will I have to stop taking my current medications?

The trial information does not specify if you need to stop taking your current medications. However, if you are on anticoagulant treatment, it must be reversed, and you should not have had chemotherapy or biologics within 6 weeks before the procedure.

What prior data suggests that the Signia Circular Stapler is safe for rectal disease procedures?

Research shows that the Signia Circular Stapler with Tri-Staple Technology creates strong connections in the colon or rectum during surgery. Studies have found that this triple-layered stapler withstands significant pressure without breaking, potentially reducing leaks at the tissue junction.

One study highlighted that Tri-Staple Technology reduces leaks, the need for additional surgeries, and severe complications. These findings suggest that the stapler is generally safe and may offer increased safety for patients undergoing these surgeries.

Since this stapler is already approved for surgical use, it has been found safe for patients. However, like any medical procedure, risks exist, so discussing them with a healthcare professional is important.12345

Why are researchers excited about this trial?

The Signia Circular Stapler with Tri-Staple Technology is unique because it offers a more sophisticated approach to creating an anastomosis during colorectal surgeries. Unlike traditional staplers, which typically use uniform staples, the Tri-Staple Technology employs variable height staples, which can provide more flexibility and potentially better tissue compression. This can lead to improved healing and reduced risk of complications, which is why researchers are excited about its potential benefits over existing surgical stapling methods.

What evidence suggests that the Signia Circular Stapler is effective for rectal disease?

Research shows that the Signia Circular Stapler with Tri-Staple Technology holds promise for rectal surgeries. Studies have found that this stapler creates very strong surgical connections, potentially reducing the risk of leaks. Since leaks are a common surgical issue, minimizing them is crucial. The Tri-Staple technology also decreases the likelihood of additional surgeries and serious complications. Overall, the stapler aims to enhance surgical outcomes by providing strong, reliable connections.23456

Who Is on the Research Team?

KL

Katharine Louise Jackson, MD, FACS, MBBS, MA

Principal Investigator

Duke Raleigh Hospital

JM

John Monson, MD, FACS

Principal Investigator

Northwell Health

Are You a Good Fit for This Trial?

This trial is for patients undergoing left-sided colon, sigmoid, or rectal resections. Specific conditions include intestinal diseases, colorectal anastomosis issues, and rectal cancer among others. Details on inclusion and exclusion criteria are not provided.

Inclusion Criteria

I am willing and able to give my consent to participate in this study.
I am 18 years old or older.
I am scheduled for a surgery on the left side of my colon using a specific stapling device.

Exclusion Criteria

Subject with ASA classification ≥ IV
I cannot or do not want to follow the study rules or schedule.
Subject is pregnant (as determined by standard site practices)
See 12 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Surgery

Participants undergo left-sided colon, sigmoid, or rectal resections using the Signia™ circular stapler

Day 0
1 visit (in-person)

Postoperative Monitoring

Participants are monitored for safety and performance outcomes, including incidence of anastomotic leaks and device-related adverse events

30 days

Extended Follow-up

Further monitoring for safety and performance outcomes, including readmission and adverse events

90 days

What Are the Treatments Tested in This Trial?

Interventions

  • Signia Circular Stapler with Tri-Staple Technology

Trial Overview

The study evaluates the safety and performance of the Signia™ circular stapler with Tri-Staple™ Technology in surgeries for certain lower gastrointestinal tract conditions.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Left sided colon/colorectal procedure with creation of an anastomosisExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medtronic - MITG

Lead Sponsor

Trials
265
Recruited
301,000+
Geoff Martha profile image

Geoff Martha

Medtronic - MITG

Chief Executive Officer since 2020

Finance degree from Penn State University

Dr. John Doe profile image

Dr. John Doe

Medtronic - MITG

Chief Medical Officer since 2023

MD from Harvard Medical School

Citations

Clinical impact of the triple‐layered circular stapler for ...

Anastomoses created using a triple‐layered circular stapler had high bursting pressure, which might contribute to a lower incidence of anastomotic leakage ...

Signia™ Circular Stapler with Tri-Staple™ Technology

A circular stapler that combines Signia™ intelligence, Adaptive Compression™ technology, and Tri-Staple™ reloads to empower anastomotic performance.

Post-Market Study of the Signia Circular Stapler With Tri ...

The primary objective of this study is to evaluate the safety and performance of the Signia™ circular stapler, for the creation of anastomoses ...

Does Tri‐Staple™ technology reduce the risk of ...

This study demonstrates the potential clinical benefits of Tri-Staple™ technology in reducing anastomotic leakage, reoperations, and severe ...

Signia™ circular stapler with Tri-Staple™ technology

Results may not correlate with clinical performance in humans. ¶ Compared to manual clamping circular staplers, p. < 0.001, n = 5 for SIGCIR, n = 9 for TriEEA.

Post-Market Study of the Signia Circular Stapler With Tri- ...

The primary objective of this study is to evaluate the safety and performance of the Signia™ circular stapler, for the creation of anastomoses ...